Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine Misoprostol for PPH Prevention in C-Section
NCT03390010Phase 1Completed
- Sponsor
- Al Jazeera Hospital
- Start
- Dec 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Al Jazeera Hospital. Primary endpoint: The number of participants who passed cesarean section without postpartum hemorage at 2 days. Started Dec 2017; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03390010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390010.